To include your compound in the COVID-19 Resource Center, submit it here.

Allogene, Stanford to investigate tool for creating allogeneic cell therapies

Crafting allogeneic cell therapies relies on the ability to modify the cells, and Allogene will collaborate with three Stanford University professors to access a new method

Read the full 268 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE